{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T06:27:37Z","timestamp":1787639257866,"version":"build-2736575974"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T00:00:00Z","timestamp":1647820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Purpose<\/jats:title>\n<jats:p>Encapsulating Peritoneal Sclerosis (EPS) is the most serious complication of long-term peritoneal dialysis (PD), which considerably reduces the patient\u2019s quality of life, leading to patients discontinuing PD. Considering these negative effects, it is necessary to systematically review and determine the risk factors of EPS.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>The PubMed, Embase, Web of Science, Cochrane Library, and China Biology Medicine (CBM) were searched from their inception to January 1<jats:sup>st<\/jats:sup>, 2022, and the bibliographies from the citations of relevant articles were manually searched. The ROBINS-I (Risk of Bias in Non-randomized studies of Interventions) tool was used to evaluate the risk of bias of included studies.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Ten studies involving 12595 participants were included in this meta-analysis. The results revealed that a younger age at PD onset (MD = -7.70, 95% CI, -11.53~-3.86), a higher transporter (MD = 0.13, 95% CI, 0.09~0.18), a longer PD duration (SMD = 1.15, 95% CI, 0.68~1.61), a longer peritonitis duration (MD = 12.66, 95% CI, 3.85~21.47), and history of glomerulonephritis (OR = 1.42, 95% CI, 1.02~1.97) were significant risk factors for EPS. However, sex, use of icodextrin, the number of peritonitis episodes, and history of multicystic kidney disease did not affect the risk of EPS.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>This review provides a scientific basis for further understanding the etiology of PD-related EPS and improving prevention strategies. More high-quality studies are necessary to validate this paper\u2019s findings.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0265584","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T17:32:12Z","timestamp":1647883932000},"page":"e0265584","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Risk factors for Encapsulating Peritoneal Sclerosis in patients undergoing peritoneal dialysis: A meta-analysis"],"prefix":"10.1371","volume":"17","author":[{"given":"Dashan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6434-4759","authenticated-orcid":true,"given":"Yonggui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,3,21]]},"reference":[{"issue":"9","key":"pone.0265584.ref001","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrneph.2011.93","article-title":"Encapsulating peritoneal sclerosis: the state of affairs","volume":"7","author":"M Korte","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"pone.0265584.ref002","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1177\/089686080002004S04","article-title":"Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis","author":"Y Kawaguchi","year":"2000","journal-title":"Perit Dial Int"},{"key":"pone.0265584.ref003","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1177\/089686080102103S10","article-title":"Diagnosis and management of encapsulating peritoneal sclerosis","author":"C Pollock","year":"2001","journal-title":"Perit Dial Int"},{"issue":"6","key":"pone.0265584.ref004","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/ki.2010.186","article-title":"The peritoneal osmotic conductance is low well before the diagnosis of encapsulating peritoneal sclerosis is made","volume":"78","author":"M Lambie","year":"2010","journal-title":"Kidney Int"},{"issue":"7","key":"pone.0265584.ref005","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.ajpath.2017.03.007","article-title":"miR-21 Promotes Fibrogenesis in Peritoneal Dialysis","volume":"187","author":"M Lopez-Anton","year":"2017","journal-title":"Am J Pathol"},{"issue":"11","key":"pone.0265584.ref006","doi-asserted-by":"crossref","first-page":"e112050","DOI":"10.1371\/journal.pone.0112050","article-title":"Patients with encapsulating peritoneal sclerosis have increased peritoneal expression of connective tissue growth factor (CCN2), transforming growth factor-\u03b21, and vascular endothelial growth factor","volume":"9","author":"A Abrahams","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"pone.0265584.ref007","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/ndt\/gfv440","article-title":"Peritoneal inflammation precedes encapsulating peritoneal sclerosis: results from the GLOBAL Fluid Study","volume":"31","author":"MR Lambie","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"pone.0265584.ref008","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s10157-015-1081-7","article-title":"Long-term outcome of encapsulating peritoneal sclerosis (EPS) patients in a single center","volume":"19","author":"A Yamahatsu","year":"2015","journal-title":"Clin Exp Nephrol"},{"issue":"22","key":"pone.0265584.ref009","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/ijms20225765","article-title":"Encapsulating Peritoneal Sclerosis: Pathophysiology and Current Treatment Options","volume":"20","author":"R Jagirdar","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"4","key":"pone.0265584.ref010","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3747\/pdi.2017.00018","article-title":"Length of Time on Peritoneal Dialysis and Encapsulating Peritoneal Sclerosis\u2014Position Paper for ISPD: 2017 Update","volume":"37","author":"E Brown","year":"2017","journal-title":"Perit Dial Int"},{"issue":"2","key":"pone.0265584.ref011","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3747\/pdi.2016.00109","article-title":"Significant Decreasing Incidence of Encapsulating Peritoneal Sclerosis in the Dutch Population of Peritoneal Dialysis Patients","volume":"37","author":"M Betjes","year":"2017","journal-title":"Perit Dial Int"},{"issue":"7","key":"pone.0265584.ref012","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.2215\/CJN.01260209","article-title":"Encapsulating peritoneal sclerosis in the new millennium: a national cohort study","volume":"4","author":"M Brown","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"pone.0265584.ref013","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0272-6386(04)00953-9","article-title":"Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study","volume":"44","author":"H Kawanishi","year":"2004","journal-title":"Am J kidney Dis"},{"issue":"1","key":"pone.0265584.ref014","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/ndt\/13.1.154","article-title":"Sclerosing peritonitis: the experience in Australia","volume":"13","author":"R Rigby","year":"1998","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"pone.0265584.ref015","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/ki.2010.16","article-title":"Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes","volume":"77","author":"DW Johnson","year":"2010","journal-title":"Kidney Int"},{"key":"pone.0265584.ref016","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1046\/j.1440-1797.8.s.11.x","article-title":"Sclerosing encapsulating peritonitis as a complication of long-term continuous ambulatory peritoneal dialysis in Korea","author":"H Lee","year":"2003","journal-title":"Nephrology (Carlton, Vic)"},{"issue":"5","key":"pone.0265584.ref017","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/ndt\/gfp677","article-title":"Risk factors for developing encapsulating peritoneal sclerosis in the icodextrin era of peritoneal dialysis prescription","volume":"25","author":"A Habib","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"pone.0265584.ref018","first-page":"75","article-title":"Incidence of encapsulating peritoneal sclerosis at a single U.S. university center","volume":"26","author":"S Bansal","year":"2010","journal-title":"Adv Perit Dial"},{"key":"pone.0265584.ref019","first-page":"131","article-title":"High-transport membrane is a risk factor for encapsulating peritoneal sclerosis developing after long-term continuous ambulatory peritoneal dialysis treatment","volume":"18","author":"R Yamamoto","year":"2002","journal-title":"Adv Perit Dial"},{"issue":"4","key":"pone.0265584.ref020","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1053\/j.ajkd.2005.12.049","article-title":"Encapsulating peritoneal sclerosis: an unpredictable and devastating complication of peritoneal dialysis","volume":"47","author":"A Chin","year":"2006","journal-title":"Am J kidney Dis"},{"issue":"1","key":"pone.0265584.ref021","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1080\/0886022X.2016.1244075","article-title":"Risk factors of severe peritoneal sclerosis in chronic peritoneal dialysis patients","volume":"39","author":"S Alatab","year":"2017","journal-title":"Ren Fail"},{"key":"pone.0265584.ref022","first-page":"8250589","article-title":"Encapsulating Peritoneal Sclerosis in Long-Termed Peritoneal Dialysis Patients","volume":"2018","author":"HJ Hsu","year":"2018","journal-title":"Biomed Res Int"},{"key":"pone.0265584.ref023","doi-asserted-by":"crossref","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"MJ Page","year":"2021","journal-title":"BMJ"},{"issue":"5","key":"pone.0265584.ref024","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"8","author":"D Moher","year":"2010","journal-title":"Int J Surg"},{"key":"pone.0265584.ref025","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"JA Sterne","year":"2016","journal-title":"BMJ"},{"issue":"4","key":"pone.0265584.ref026","first-page":"429","article-title":"Encapsulated peritoneal sclerosis: a single center, retrospective analysis of clinical manifestations, risk factors and prognosis","volume":"70","author":"Y Koc","year":"2018","journal-title":"Minerva Urol Nefrol"},{"issue":"3","key":"pone.0265584.ref027","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3747\/pdi.2010.00167","article-title":"Risk factors associated with encapsulating peritoneal sclerosis in Dutch EPS study","volume":"31","author":"MR Korte","year":"2011","journal-title":"Perit Dial Int"},{"issue":"11","key":"pone.0265584.ref028","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/nep.12911","article-title":"Risk factors for encapsulating peritoneal sclerosis: Analysis of a 36-year experience in a University Hospital","volume":"22","author":"M Nakao","year":"2017","journal-title":"Nephrology (Carlton, Vic)"},{"issue":"1","key":"pone.0265584.ref029","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/1744-9987.12048","article-title":"Risk factors for encapsulating peritoneal sclerosis in long-term peritoneal dialysis: a retrospective observational study","volume":"18","author":"M Nakao","year":"2014","journal-title":"Ther Apher Dial"},{"issue":"2","key":"pone.0265584.ref030","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s10157-005-0349-8","article-title":"Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatment","volume":"9","author":"R Yamamoto","year":"2005","journal-title":"Clin Exp Nephrol"},{"issue":"4","key":"pone.0265584.ref031","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3109\/08860221003658274","article-title":"Encapsulating peritoneal sclerosis: experience of a tertiary referral center","volume":"32","author":"P Phelan","year":"2010","journal-title":"Ren Fail"},{"issue":"2","key":"pone.0265584.ref032","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000170262","article-title":"Effect of peritoneal dialysis on cytokine production by peritoneal cells","volume":"14","author":"N Topley","year":"1996","journal-title":"Blood Purif"},{"key":"pone.0265584.ref033","doi-asserted-by":"crossref","first-page":"3543678","DOI":"10.1155\/2016\/3543678","article-title":"Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis","volume":"2016","author":"R Strippoli","year":"2016","journal-title":"Stem Cells Int"},{"key":"pone.0265584.ref034","first-page":"144","article-title":"Risk factors and preventive measures for encapsulating peritoneal sclerosis\u2014Jikei experience 2002","volume":"18","author":"M Nakayama","year":"2002","journal-title":"Adv Perit Dial"},{"issue":"4","key":"pone.0265584.ref035","first-page":"396","article-title":"Long-standing high-transport membrane as a risk factor for EPS development after PD withdrawal: an analysis based on changes in peritoneal function during and after CAPD withdrawal","volume":"44","author":"M Nakayama","year":"2002","journal-title":"Nihon Jinzo Gakkai Shi"},{"issue":"3","key":"pone.0265584.ref036","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1177\/089686080102103S12","article-title":"The greater incidence of encapsulating peritoneal sclerosis is not the result of overdiagnosis","volume":"21","author":"M. Nakayama","year":"2001","journal-title":"Perit Dial Int"},{"issue":"2","key":"pone.0265584.ref037","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000170263","article-title":"Cytokine patterns in the effluent of continuous ambulatory peritoneal dialysis: relationship to peritoneal permeability","volume":"14","author":"D Zemel","year":"1996","journal-title":"Blood Purif"},{"issue":"3","key":"pone.0265584.ref038","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000186154","article-title":"Intraperitoneal secretion of interleukin-6 during continuous ambulatory peritoneal dialysis","volume":"56","author":"M Goldman","year":"1990","journal-title":"Nephron"},{"issue":"2","key":"pone.0265584.ref039","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11255-010-9848-y","article-title":"Encapsulating peritoneal sclerosis: a single-center experience and review of the literature","volume":"43","author":"K Trigka","year":"2011","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"pone.0265584.ref040","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s40620-015-0241-x","article-title":"Encapsulating peritoneal sclerosis in an Italian center: thirty year experience","volume":"29","author":"V Vizzardi","year":"2016","journal-title":"J Nephrol"},{"issue":"1","key":"pone.0265584.ref041","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000349999","article-title":"Encapsulating peritoneal sclerosis: a rare complication of peritoneal dialysis in Al-ain, United arab emirates","volume":"3","author":"S Abouchacra","year":"2013","journal-title":"Case Rep Nephrol Urol"},{"issue":"1","key":"pone.0265584.ref042","doi-asserted-by":"crossref","first-page":"e0190079","DOI":"10.1371\/journal.pone.0190079","article-title":"Incidence and outcomes of encapsulating peritoneal sclerosis (EPS) and factors associated with severe EPS","volume":"13","author":"CC Tseng","year":"2018","journal-title":"PLoS One"},{"issue":"8341","key":"pone.0265584.ref043","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0140-6736(83)90106-X","article-title":"Sclerosing obstructive peritonitis after continuous ambulatory peritoneal dialysis","volume":"2","author":"JA Bradley","year":"1983","journal-title":"Lancet"},{"issue":"5","key":"pone.0265584.ref044","doi-asserted-by":"crossref","first-page":"A113","DOI":"10.1016\/0002-9343(84)91017-9","article-title":"Peritoneal dialysis complicated by fungal peritonitis and peritoneal fibrosis","volume":"76","author":"M Flanigan","year":"1984","journal-title":"Am J Med"},{"issue":"4","key":"pone.0265584.ref045","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/ndt\/12.4.821","article-title":"Relapsing CAPD peritonitis with rapid peritoneal sclerosis due to Haemophilus influenzae","volume":"12","author":"CG Chew","year":"1997","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"pone.0265584.ref046","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3747\/pdi.2010.00196","article-title":"Incidence of encapsulating peritoneal sclerosis: a single-center experience with long-term peritoneal dialysis in the United States","volume":"31","author":"C Gayomali","year":"2011","journal-title":"Perit Dial Int"},{"issue":"5","key":"pone.0265584.ref047","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1111\/j.1523-1755.2005.00701.x","article-title":"Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure","volume":"68","author":"A Summers","year":"2005","journal-title":"Kidney Int"},{"issue":"3","key":"pone.0265584.ref048","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0272-6386(96)90501-6","article-title":"Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group","volume":"28","author":"Y Nomoto","year":"1996","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"pone.0265584.ref049","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1177\/089686080502504S04","article-title":"Pathology of encapsulating peritoneal sclerosis","volume":"25","author":"K Honda","year":"2005","journal-title":"Perit Dial Int"},{"issue":"5","key":"pone.0265584.ref050","doi-asserted-by":"crossref","first-page":"e96377","DOI":"10.1371\/journal.pone.0096377","article-title":"Tacrolimus increases Nox4 expression in human renal fibroblasts and induces fibrosis-related genes by aberrant TGF-beta receptor signalling","volume":"9","author":"G Kern","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"pone.0265584.ref051","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00467-008-1055-z","article-title":"Expression of fibrosis-associated molecules in IgA nephropathy treated with cyclosporine","volume":"24","author":"B Lim","year":"2009","journal-title":"Pediatr Nephrol"},{"issue":"19","key":"pone.0265584.ref052","doi-asserted-by":"crossref","first-page":"10252","DOI":"10.3390\/ijms221910252","article-title":"Chrysin Ameliorates Cyclosporine-A-Induced Renal Fibrosis by Inhibiting TGF-\u03b2-Induced Epithelial-Mesenchymal Transition","volume":"22","author":"R Nagavally","year":"2021","journal-title":"Int J Mol Sci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0265584","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T17:33:02Z","timestamp":1647883982000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0265584"}},"subtitle":[],"editor":[{"given":"Wisit","family":"Cheungpasitporn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,3,21]]},"references-count":52,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0265584","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,21]]}}}